Skip to search formSkip to main contentSkip to account menu

fengabine

Known as: 2-(N-butyl-o-chlorobenzimidoyl)-4-chlorophenyl 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
1. The effects of fengabine were compared with those of amitriptyline in healthy elderly volunteers. Doses were administered… 
1991
1991
A double‐blind controlled trial of Fengabine, a GABA agonist, against placebo was carried out in outpatient major depressives… 
Review
1989
Review
1989
Fengabine is a new GABAmimetic compound active in animal models predictive of antidepressant activity. The present overview… 
Review
1989
Review
1989
Evidence suggests the involvement of the GABAergic (γ-aminobutyric acid) system in affective disorders and the therapeutic action… 
1989
1989
Fengabine is a new γ-aminobutyric acid (GABA)-mimetic drug with atypical antidepressant activity in various models of depression… 
Review
1989
Review
1989
The development of antidepressant drugs has traditionally been based on the potentiation of central monoaminergic synaptic… 
1988
1988
The effect of fengabine (a novel benzylidene derivative) on neuropsychopharmacological parameters was investigated in mice. On… 
1988
1988
The effect of fengabine (a novel benzylidene derivative) on neuropsychopharmacological parameters was investigated in mice. On… 
Review
1987
Review
1987
Recently sufficient evidence has accumulated to propose that a central GABAergic dysfunction may be primarily related to the…